Back to today’s briefing

Story perspectives

Breakthrough Study Reveals Genetic Mutation Boosts Antiviral Defense

8/19/2025

41 4

Summary

Story summary

A study by Columbia University identifies a genetic mutation that enhances antiviral capabilities through ISG15 deficiency.
Researchers created a nasal antiviral therapy using lipid nanoparticles to boost ISG15-like protection temporarily.
Initial tests on hamsters and mice demonstrated effectiveness against influenza and SARS-CoV-2.
Future research will focus on increasing protein production and evaluating immunity duration.

1 of 1

Story summary

A study by Columbia University identifies a genetic mutation that enhances antiviral capabilities through ISG15 deficiency.
Researchers created a nasal antiviral therapy using lipid nanoparticles to boost ISG15-like protection temporarily.
Initial tests on hamsters and mice demonstrated effectiveness against influenza and SARS-CoV-2.
Future research will focus on increasing protein production and evaluating immunity duration.